Patients with type 2 diabetes (T2D) at an elevated risk for kidney failure may stand to gain the most renal benefit with intensive glycemic control, but they also face the highest overall risk for ...
It's long been known that use of a renin-angiotensin-aldosterone system (RAAS) antagonist slows the progression of kidney disease and specifically slows progression of advanced kidney disease, ...
PARIS, France—Two new renal denervation (RDN) systems seem to be safe and effective in patients with uncontrolled hypertension, according to presentations here at EuroPCR 2023. In the SMART trial, a ...
Over 100 million Americans currently live with high blood pressure, yet many remain unaware of its profound connection to kidney health. This relationship represents one of medicine’s most critical ...
Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized small renal masses, supporting its role as a surgery-sparing local ...
Personalized neoantigen vaccines show promise in activating immune responses and controlling tumors in kidney cancer patients. A phase 1 trial demonstrated neoantigen-specific T-cell responses and ...
Please provide your email address to receive an email when new articles are posted on . Tivozanib induced a significantly higher disease control rate than sorafenib among patients with relapsed or ...
Kidney disease develops when the kidneys become damaged and can no longer remove waste products, extra water, and toxins from ...
Please provide your email address to receive an email when new articles are posted on . Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset ...
A new study has identified a critical "pressure sensor" inside the kidney that helps the body control blood pressure and fluid levels. The finding helps explain how the kidneys sense changes in blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results